Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplastic Cells, Circulating | 26 | 2022 | 934 | 3.090 |
Why?
|
Carcinoma, Pancreatic Ductal | 21 | 2024 | 1636 | 2.680 |
Why?
|
Pancreatic Neoplasms | 30 | 2024 | 5263 | 2.430 |
Why?
|
In Situ Hybridization | 14 | 2021 | 1950 | 1.350 |
Why?
|
Liver Diseases | 3 | 2020 | 1253 | 1.130 |
Why?
|
Adenocarcinoma, Mucinous | 3 | 2022 | 507 | 1.110 |
Why?
|
RNA, Satellite | 2 | 2022 | 17 | 0.900 |
Why?
|
Tumor Microenvironment | 15 | 2023 | 3590 | 0.890 |
Why?
|
Repetitive Sequences, Nucleic Acid | 4 | 2018 | 798 | 0.870 |
Why?
|
Carcinoma, Hepatocellular | 7 | 2021 | 2214 | 0.830 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2022 | 248 | 0.800 |
Why?
|
Colonic Neoplasms | 6 | 2023 | 2542 | 0.780 |
Why?
|
RNA, Neoplasm | 7 | 2019 | 769 | 0.770 |
Why?
|
Liver Neoplasms | 8 | 2023 | 4253 | 0.730 |
Why?
|
Epithelial Cells | 7 | 2020 | 3690 | 0.720 |
Why?
|
HMGA2 Protein | 1 | 2020 | 123 | 0.710 |
Why?
|
Gene Expression Regulation, Neoplastic | 20 | 2022 | 8432 | 0.690 |
Why?
|
Epithelial-Mesenchymal Transition | 8 | 2022 | 713 | 0.630 |
Why?
|
Chimerism | 1 | 2019 | 158 | 0.630 |
Why?
|
Adenocarcinoma | 12 | 2023 | 6364 | 0.610 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2019 | 990 | 0.570 |
Why?
|
Research Support as Topic | 1 | 2020 | 705 | 0.530 |
Why?
|
DNA, Satellite | 2 | 2015 | 69 | 0.520 |
Why?
|
Serum Albumin | 2 | 2015 | 675 | 0.520 |
Why?
|
Azacitidine | 1 | 2017 | 347 | 0.510 |
Why?
|
Cell Line, Tumor | 30 | 2022 | 16690 | 0.500 |
Why?
|
Colorectal Neoplasms | 8 | 2023 | 6773 | 0.500 |
Why?
|
RNA-Binding Proteins | 2 | 2021 | 1903 | 0.490 |
Why?
|
Neoplasm Metastasis | 8 | 2022 | 4851 | 0.430 |
Why?
|
Carcinoma, Papillary | 1 | 2017 | 783 | 0.410 |
Why?
|
RNA, Untranslated | 2 | 2015 | 453 | 0.400 |
Why?
|
Receptors, Androgen | 6 | 2018 | 1058 | 0.390 |
Why?
|
Precancerous Conditions | 2 | 2017 | 975 | 0.390 |
Why?
|
Leucovorin | 6 | 2022 | 628 | 0.380 |
Why?
|
Ovarian Neoplasms | 3 | 2023 | 4839 | 0.360 |
Why?
|
Mice, Inbred NOD | 6 | 2020 | 1879 | 0.350 |
Why?
|
MicroRNAs | 3 | 2020 | 3751 | 0.350 |
Why?
|
Sequence Analysis, RNA | 12 | 2020 | 2012 | 0.350 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2760 | 0.350 |
Why?
|
Neoadjuvant Therapy | 8 | 2022 | 2727 | 0.340 |
Why?
|
Cell Separation | 6 | 2017 | 1751 | 0.330 |
Why?
|
Graft vs Tumor Effect | 1 | 2008 | 72 | 0.320 |
Why?
|
Mice, SCID | 5 | 2022 | 2716 | 0.320 |
Why?
|
Fluorouracil | 6 | 2022 | 1619 | 0.310 |
Why?
|
Interferons | 2 | 2022 | 706 | 0.310 |
Why?
|
Barrett Esophagus | 2 | 2023 | 494 | 0.300 |
Why?
|
RNA, Messenger | 6 | 2017 | 13035 | 0.300 |
Why?
|
Lymphocyte Transfusion | 1 | 2008 | 236 | 0.300 |
Why?
|
Humans | 113 | 2024 | 744366 | 0.300 |
Why?
|
Cholangiocarcinoma | 3 | 2019 | 516 | 0.290 |
Why?
|
Long Interspersed Nucleotide Elements | 4 | 2023 | 338 | 0.290 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 9 | 2022 | 11525 | 0.290 |
Why?
|
Extracellular Matrix | 1 | 2014 | 1741 | 0.280 |
Why?
|
RNA | 6 | 2022 | 2749 | 0.280 |
Why?
|
Transplantation Chimera | 2 | 2008 | 613 | 0.280 |
Why?
|
DNA Methylation | 3 | 2017 | 4285 | 0.270 |
Why?
|
Stromal Cells | 3 | 2021 | 1355 | 0.260 |
Why?
|
Breast Neoplasms | 13 | 2022 | 20824 | 0.260 |
Why?
|
Biomedical Research | 1 | 2020 | 3309 | 0.250 |
Why?
|
Transplantation Conditioning | 2 | 2008 | 1599 | 0.240 |
Why?
|
Female | 60 | 2023 | 380193 | 0.230 |
Why?
|
Immunohistochemistry | 11 | 2022 | 11366 | 0.230 |
Why?
|
Mice | 30 | 2023 | 81201 | 0.220 |
Why?
|
Organoplatinum Compounds | 2 | 2015 | 408 | 0.220 |
Why?
|
Animals | 36 | 2023 | 168768 | 0.220 |
Why?
|
Alkylating Agents | 1 | 2023 | 139 | 0.220 |
Why?
|
DNA Mismatch Repair | 2 | 2022 | 426 | 0.210 |
Why?
|
Retroelements | 1 | 2023 | 164 | 0.210 |
Why?
|
Genomic Instability | 2 | 2016 | 695 | 0.210 |
Why?
|
Cell Differentiation | 3 | 2016 | 11486 | 0.200 |
Why?
|
Esophageal Neoplasms | 2 | 2023 | 1585 | 0.200 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2019 | 5172 | 0.200 |
Why?
|
RNA, Viral | 3 | 2021 | 2901 | 0.200 |
Why?
|
Microfluidics | 3 | 2017 | 662 | 0.200 |
Why?
|
Life Cycle Stages | 1 | 2022 | 160 | 0.200 |
Why?
|
Microglia | 2 | 2020 | 1267 | 0.200 |
Why?
|
Neuroendocrine Tumors | 2 | 2019 | 594 | 0.200 |
Why?
|
Carcinoma | 2 | 2023 | 2375 | 0.200 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2023 | 2949 | 0.190 |
Why?
|
Glioma | 3 | 2020 | 3401 | 0.190 |
Why?
|
Prognosis | 13 | 2024 | 29060 | 0.190 |
Why?
|
Lamivudine | 1 | 2022 | 342 | 0.190 |
Why?
|
Male | 49 | 2023 | 350115 | 0.190 |
Why?
|
Bone Neoplasms | 3 | 2019 | 2530 | 0.190 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2020 | 52 | 0.190 |
Why?
|
Microfluidic Analytical Techniques | 3 | 2017 | 828 | 0.190 |
Why?
|
Glioblastoma | 3 | 2020 | 3481 | 0.180 |
Why?
|
DNA, Neoplasm | 2 | 2019 | 1758 | 0.180 |
Why?
|
Wnt Proteins | 2 | 2015 | 721 | 0.180 |
Why?
|
Bile Duct Neoplasms | 2 | 2015 | 567 | 0.180 |
Why?
|
Chromatin Assembly and Disassembly | 2 | 2014 | 634 | 0.180 |
Why?
|
Kaplan-Meier Estimate | 6 | 2020 | 6539 | 0.170 |
Why?
|
Transferrin | 1 | 2020 | 295 | 0.170 |
Why?
|
RNA Stability | 1 | 2021 | 321 | 0.170 |
Why?
|
Oligonucleotides, Antisense | 1 | 2021 | 433 | 0.170 |
Why?
|
Lymphoma | 1 | 2008 | 1877 | 0.170 |
Why?
|
Tumor Cells, Cultured | 5 | 2021 | 6313 | 0.170 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2021 | 2026 | 0.170 |
Why?
|
Brain Neoplasms | 4 | 2020 | 8861 | 0.170 |
Why?
|
Lipogenesis | 1 | 2020 | 212 | 0.170 |
Why?
|
Placenta Diseases | 1 | 2021 | 199 | 0.170 |
Why?
|
Interspersed Repetitive Sequences | 1 | 2019 | 54 | 0.170 |
Why?
|
Neoplasms | 7 | 2018 | 21696 | 0.160 |
Why?
|
Prostatic Neoplasms | 8 | 2022 | 11126 | 0.160 |
Why?
|
Acetamides | 1 | 2020 | 249 | 0.160 |
Why?
|
Retroperitoneal Space | 1 | 2019 | 176 | 0.160 |
Why?
|
Single-Cell Analysis | 6 | 2020 | 2182 | 0.160 |
Why?
|
Cell Movement | 4 | 2020 | 5218 | 0.160 |
Why?
|
Ribosomes | 1 | 2021 | 500 | 0.160 |
Why?
|
Azepines | 1 | 2020 | 334 | 0.160 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 109 | 0.160 |
Why?
|
Skull Neoplasms | 1 | 2019 | 173 | 0.160 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2019 | 116 | 0.160 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2019 | 188 | 0.160 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5445 | 0.160 |
Why?
|
Middle Aged | 29 | 2021 | 213390 | 0.160 |
Why?
|
Organoids | 2 | 2022 | 701 | 0.160 |
Why?
|
Facial Bones | 1 | 2019 | 201 | 0.160 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 5 | 2024 | 1038 | 0.150 |
Why?
|
DNA Contamination | 1 | 2017 | 19 | 0.150 |
Why?
|
DNA | 4 | 2022 | 7294 | 0.150 |
Why?
|
DNA Damage | 2 | 2019 | 2432 | 0.150 |
Why?
|
Ribosomal Proteins | 1 | 2020 | 360 | 0.150 |
Why?
|
Salivary Glands | 1 | 2019 | 229 | 0.150 |
Why?
|
Forkhead Transcription Factors | 5 | 2022 | 1613 | 0.150 |
Why?
|
Aged | 24 | 2022 | 163288 | 0.150 |
Why?
|
RANK Ligand | 1 | 2019 | 326 | 0.150 |
Why?
|
Disease-Free Survival | 7 | 2021 | 6896 | 0.150 |
Why?
|
Neoplasm Invasiveness | 3 | 2022 | 3616 | 0.150 |
Why?
|
Losartan | 1 | 2019 | 299 | 0.150 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2024 | 1366 | 0.150 |
Why?
|
Genetic Heterogeneity | 2 | 2019 | 733 | 0.150 |
Why?
|
Lamin Type B | 1 | 2016 | 25 | 0.150 |
Why?
|
Prolactin | 1 | 2019 | 669 | 0.140 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 627 | 0.140 |
Why?
|
Transforming Growth Factor beta | 2 | 2023 | 2007 | 0.140 |
Why?
|
Androstenes | 1 | 2018 | 170 | 0.140 |
Why?
|
Macrophages | 3 | 2020 | 5660 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 381 | 0.140 |
Why?
|
beta-Globins | 1 | 2017 | 115 | 0.140 |
Why?
|
Cell Proliferation | 7 | 2021 | 10483 | 0.140 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2021 | 3554 | 0.140 |
Why?
|
Extracellular Matrix Proteins | 1 | 2020 | 850 | 0.140 |
Why?
|
Mitotic Index | 1 | 2016 | 172 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2021 | 988 | 0.140 |
Why?
|
Liposarcoma | 1 | 2019 | 333 | 0.140 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2016 | 111 | 0.130 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2015 | 87 | 0.130 |
Why?
|
Cell Communication | 2 | 2020 | 1621 | 0.130 |
Why?
|
Neoplasm Staging | 5 | 2023 | 11031 | 0.130 |
Why?
|
Coculture Techniques | 1 | 2019 | 1341 | 0.130 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 2015 | 173 | 0.130 |
Why?
|
Anus Neoplasms | 1 | 2019 | 332 | 0.130 |
Why?
|
Retinoblastoma Protein | 1 | 2019 | 705 | 0.130 |
Why?
|
Osteonectin | 1 | 2014 | 34 | 0.130 |
Why?
|
STAT3 Transcription Factor | 1 | 2019 | 874 | 0.130 |
Why?
|
Human papillomavirus 18 | 1 | 2015 | 128 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2015 | 66 | 0.130 |
Why?
|
Phenotype | 6 | 2023 | 16367 | 0.130 |
Why?
|
Retinal Dehydrogenase | 1 | 2014 | 74 | 0.120 |
Why?
|
Centromere | 1 | 2015 | 220 | 0.120 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2014 | 105 | 0.120 |
Why?
|
Phenylthiohydantoin | 1 | 2015 | 193 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2019 | 1284 | 0.120 |
Why?
|
Pancreas | 1 | 2021 | 1687 | 0.120 |
Why?
|
Human papillomavirus 16 | 1 | 2015 | 262 | 0.120 |
Why?
|
Neuroblastoma | 1 | 2021 | 1226 | 0.120 |
Why?
|
Graft vs Host Disease | 2 | 2023 | 2958 | 0.110 |
Why?
|
Gallbladder Neoplasms | 1 | 2015 | 182 | 0.110 |
Why?
|
User-Computer Interface | 1 | 2020 | 1431 | 0.110 |
Why?
|
RNA-Binding Protein EWS | 1 | 2014 | 216 | 0.110 |
Why?
|
Signal Transduction | 8 | 2020 | 23404 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2020 | 1222 | 0.110 |
Why?
|
Aged, 80 and over | 11 | 2020 | 57776 | 0.110 |
Why?
|
Gold | 1 | 2017 | 484 | 0.110 |
Why?
|
Rectal Neoplasms | 1 | 2022 | 1205 | 0.110 |
Why?
|
Haploinsufficiency | 1 | 2014 | 328 | 0.110 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2016 | 644 | 0.110 |
Why?
|
Adenosine Triphosphate | 1 | 2019 | 2027 | 0.110 |
Why?
|
Lymph Nodes | 2 | 2023 | 3476 | 0.110 |
Why?
|
Adult | 19 | 2020 | 214052 | 0.110 |
Why?
|
Metal Nanoparticles | 1 | 2017 | 405 | 0.110 |
Why?
|
DNA Transposable Elements | 1 | 2016 | 748 | 0.110 |
Why?
|
RNA, Small Interfering | 3 | 2020 | 3505 | 0.100 |
Why?
|
Lung | 2 | 2021 | 9857 | 0.100 |
Why?
|
Albumins | 1 | 2014 | 568 | 0.100 |
Why?
|
Disease Progression | 4 | 2024 | 13286 | 0.100 |
Why?
|
Camptothecin | 1 | 2015 | 576 | 0.100 |
Why?
|
Proteomics | 2 | 2022 | 3638 | 0.100 |
Why?
|
Microsatellite Instability | 1 | 2015 | 684 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2020 | 9240 | 0.100 |
Why?
|
Placenta | 1 | 2020 | 1699 | 0.100 |
Why?
|
Mutation | 9 | 2022 | 29786 | 0.100 |
Why?
|
Transfection | 1 | 2019 | 5895 | 0.100 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 944 | 0.090 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2019 | 1581 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 602 | 0.090 |
Why?
|
Genes, BRCA1 | 1 | 2014 | 781 | 0.090 |
Why?
|
Monocytes | 1 | 2020 | 2596 | 0.090 |
Why?
|
Mice, Nude | 2 | 2022 | 3689 | 0.090 |
Why?
|
Genome, Human | 1 | 2023 | 4420 | 0.090 |
Why?
|
Biopsy | 5 | 2023 | 6755 | 0.090 |
Why?
|
Gene Expression Profiling | 4 | 2022 | 9445 | 0.090 |
Why?
|
Epigenesis, Genetic | 3 | 2022 | 3646 | 0.090 |
Why?
|
Pancreatectomy | 3 | 2021 | 804 | 0.090 |
Why?
|
HEK293 Cells | 1 | 2019 | 4208 | 0.090 |
Why?
|
Proto-Oncogene Proteins B-raf | 4 | 2022 | 2043 | 0.090 |
Why?
|
Cause of Death | 1 | 2020 | 3582 | 0.090 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2012 | 415 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 1 | 2018 | 1837 | 0.090 |
Why?
|
Antiviral Agents | 1 | 2022 | 2987 | 0.090 |
Why?
|
Up-Regulation | 4 | 2020 | 4222 | 0.090 |
Why?
|
Neurosecretory Systems | 1 | 2011 | 231 | 0.090 |
Why?
|
Nerve Tissue Proteins | 1 | 2022 | 4463 | 0.080 |
Why?
|
Lymphoma, B-Cell | 1 | 2015 | 931 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2020 | 2988 | 0.080 |
Why?
|
Transcription Factors | 2 | 2022 | 12207 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1692 | 0.080 |
Why?
|
Heterochromatin | 1 | 2011 | 296 | 0.080 |
Why?
|
Transplantation, Homologous | 3 | 2020 | 4777 | 0.080 |
Why?
|
Mucins | 2 | 2022 | 564 | 0.080 |
Why?
|
Gene Knockdown Techniques | 3 | 2020 | 1656 | 0.080 |
Why?
|
Promoter Regions, Genetic | 2 | 2017 | 5867 | 0.080 |
Why?
|
Neoplasm Transplantation | 3 | 2020 | 2086 | 0.080 |
Why?
|
DNA Replication | 1 | 2014 | 1399 | 0.080 |
Why?
|
Antineoplastic Agents | 4 | 2020 | 13693 | 0.080 |
Why?
|
Embryonic Stem Cells | 1 | 2015 | 1295 | 0.080 |
Why?
|
Disease Models, Animal | 6 | 2023 | 18034 | 0.070 |
Why?
|
Endothelial Cells | 1 | 2020 | 3486 | 0.070 |
Why?
|
Androgen Antagonists | 1 | 2015 | 1377 | 0.070 |
Why?
|
Protein Kinase Inhibitors | 2 | 2022 | 5534 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2021 | 39052 | 0.070 |
Why?
|
Receptor, erbB-2 | 1 | 2016 | 2417 | 0.070 |
Why?
|
Autopsy | 2 | 2020 | 1020 | 0.070 |
Why?
|
Steroids | 2 | 2023 | 930 | 0.070 |
Why?
|
Histones | 1 | 2016 | 2598 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1988 | 0.070 |
Why?
|
RNA Interference | 1 | 2014 | 2890 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2018 | 21748 | 0.070 |
Why?
|
Chromatin | 2 | 2015 | 2933 | 0.070 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15078 | 0.060 |
Why?
|
Mice, Knockout | 1 | 2020 | 14561 | 0.060 |
Why?
|
Antigens, Neoplasm | 1 | 2013 | 1988 | 0.060 |
Why?
|
Automation, Laboratory | 2 | 2015 | 101 | 0.060 |
Why?
|
Carcinoma in Situ | 1 | 2011 | 806 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2850 | 0.060 |
Why?
|
Immunity | 2 | 2021 | 1014 | 0.060 |
Why?
|
Drug Delivery Systems | 1 | 2016 | 2219 | 0.060 |
Why?
|
Cadherins | 2 | 2022 | 907 | 0.060 |
Why?
|
Transcription, Genetic | 3 | 2019 | 7721 | 0.060 |
Why?
|
Short Interspersed Nucleotide Elements | 1 | 2023 | 40 | 0.060 |
Why?
|
Lymph Node Excision | 2 | 2023 | 1262 | 0.060 |
Why?
|
Repressor Proteins | 1 | 2015 | 3024 | 0.060 |
Why?
|
Papillomavirus Infections | 1 | 2015 | 1587 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13104 | 0.060 |
Why?
|
Arylsulfotransferase | 1 | 2023 | 28 | 0.060 |
Why?
|
Brain | 2 | 2020 | 26388 | 0.060 |
Why?
|
Chronic Disease | 1 | 2018 | 9145 | 0.060 |
Why?
|
Alu Elements | 1 | 2023 | 119 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7282 | 0.060 |
Why?
|
Tissue Array Analysis | 2 | 2015 | 553 | 0.060 |
Why?
|
Minisatellite Repeats | 1 | 2023 | 165 | 0.060 |
Why?
|
Neoplastic Processes | 1 | 2022 | 35 | 0.060 |
Why?
|
Treatment Outcome | 9 | 2021 | 63107 | 0.050 |
Why?
|
Gene Expression | 2 | 2019 | 7798 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2017 | 3086 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2725 | 0.050 |
Why?
|
Ligands | 2 | 2022 | 3282 | 0.050 |
Why?
|
Phosphorylation | 3 | 2019 | 8436 | 0.050 |
Why?
|
Sulfotransferases | 1 | 2023 | 151 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3135 | 0.050 |
Why?
|
B-Lymphocytes | 1 | 2015 | 4666 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3242 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5511 | 0.050 |
Why?
|
Protein Isoforms | 2 | 2017 | 1730 | 0.050 |
Why?
|
National Institute of Child Health and Human Development (U.S.) | 1 | 2021 | 26 | 0.050 |
Why?
|
Cell Line | 4 | 2019 | 16000 | 0.050 |
Why?
|
MutS Homolog 2 Protein | 1 | 2022 | 200 | 0.050 |
Why?
|
Neoplasm Regression, Spontaneous | 1 | 2021 | 46 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2736 | 0.050 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 21833 | 0.050 |
Why?
|
RNA Splicing | 2 | 2016 | 908 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2014 | 5023 | 0.050 |
Why?
|
Surface-Active Agents | 1 | 2020 | 159 | 0.050 |
Why?
|
Genes, MHC Class I | 1 | 2021 | 258 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5856 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2015 | 4034 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1185 | 0.040 |
Why?
|
Phlebitis | 1 | 2019 | 31 | 0.040 |
Why?
|
Retinoid X Receptors | 1 | 2019 | 93 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2021 | 802 | 0.040 |
Why?
|
Mammary Glands, Animal | 1 | 2020 | 276 | 0.040 |
Why?
|
Survival Rate | 2 | 2016 | 12788 | 0.040 |
Why?
|
Aspartic Acid Endopeptidases | 1 | 2020 | 311 | 0.040 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2019 | 70 | 0.040 |
Why?
|
Esophagoscopy | 1 | 2020 | 390 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 2007 | 2765 | 0.040 |
Why?
|
Immunotherapy | 3 | 2021 | 4446 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2022 | 2938 | 0.040 |
Why?
|
Retrospective Studies | 7 | 2021 | 77460 | 0.040 |
Why?
|
Spheroids, Cellular | 1 | 2020 | 351 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2020 | 418 | 0.040 |
Why?
|
Stereotaxic Techniques | 1 | 2020 | 536 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 365 | 0.040 |
Why?
|
E2F Transcription Factors | 1 | 2019 | 277 | 0.040 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 112 | 0.040 |
Why?
|
Herpesviridae | 1 | 2019 | 109 | 0.040 |
Why?
|
Smad4 Protein | 1 | 2019 | 163 | 0.040 |
Why?
|
Fibroblasts | 2 | 2019 | 4162 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2007 | 1620 | 0.040 |
Why?
|
Germany | 1 | 2020 | 862 | 0.040 |
Why?
|
Cell Hypoxia | 1 | 2020 | 675 | 0.040 |
Why?
|
Microscopy, Electron | 1 | 2021 | 2646 | 0.040 |
Why?
|
Antineoplastic Agents, Hormonal | 2 | 2018 | 1524 | 0.040 |
Why?
|
Granzymes | 1 | 2019 | 271 | 0.040 |
Why?
|
Immunity, Cellular | 1 | 2023 | 1607 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2022 | 1097 | 0.040 |
Why?
|
Mice, Transgenic | 2 | 2020 | 9735 | 0.040 |
Why?
|
Endogenous Retroviruses | 1 | 2018 | 112 | 0.040 |
Why?
|
Blood Preservation | 1 | 2017 | 177 | 0.040 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2019 | 320 | 0.040 |
Why?
|
RNA Probes | 1 | 2016 | 113 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 481 | 0.040 |
Why?
|
Hematoxylin | 1 | 2016 | 64 | 0.030 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2016 | 72 | 0.030 |
Why?
|
Cyclooxygenase 2 | 1 | 2019 | 612 | 0.030 |
Why?
|
Cytoprotection | 1 | 2017 | 210 | 0.030 |
Why?
|
Abdominal Neoplasms | 1 | 2018 | 292 | 0.030 |
Why?
|
Dinoprostone | 1 | 2019 | 601 | 0.030 |
Why?
|
Anal Canal | 1 | 2019 | 376 | 0.030 |
Why?
|
Tumor Escape | 1 | 2019 | 350 | 0.030 |
Why?
|
Phenylurea Compounds | 1 | 2019 | 528 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2571 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2017 | 393 | 0.030 |
Why?
|
U937 Cells | 1 | 2015 | 268 | 0.030 |
Why?
|
Plasma Cells | 1 | 2019 | 591 | 0.030 |
Why?
|
Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2015 | 17 | 0.030 |
Why?
|
X Chromosome Inactivation | 1 | 2017 | 224 | 0.030 |
Why?
|
Survival Analysis | 2 | 2020 | 10252 | 0.030 |
Why?
|
Hematologic Neoplasms | 1 | 2007 | 1832 | 0.030 |
Why?
|
Databases, Factual | 2 | 2020 | 7730 | 0.030 |
Why?
|
Risk Assessment | 3 | 2021 | 23336 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1073 | 0.030 |
Why?
|
gamma Catenin | 1 | 2014 | 44 | 0.030 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2020 | 871 | 0.030 |
Why?
|
Arginase | 1 | 2015 | 79 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2021 | 1405 | 0.030 |
Why?
|
Cell Survival | 2 | 2017 | 5882 | 0.030 |
Why?
|
Spiral Cone-Beam Computed Tomography | 1 | 2015 | 36 | 0.030 |
Why?
|
Radiotherapy | 1 | 2021 | 1533 | 0.030 |
Why?
|
Protein Binding | 2 | 2019 | 9384 | 0.030 |
Why?
|
Rad51 Recombinase | 1 | 2014 | 189 | 0.030 |
Why?
|
Tumor Burden | 1 | 2020 | 1915 | 0.030 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2015 | 295 | 0.030 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2017 | 504 | 0.030 |
Why?
|
Nucleic Acid Hybridization | 1 | 2015 | 1375 | 0.030 |
Why?
|
Surface Properties | 1 | 2017 | 1184 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 644 | 0.030 |
Why?
|
Platelet Activation | 1 | 2017 | 674 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1782 | 0.030 |
Why?
|
Centrosome | 1 | 2014 | 201 | 0.030 |
Why?
|
England | 1 | 2015 | 522 | 0.030 |
Why?
|
Coloring Agents | 1 | 2016 | 566 | 0.030 |
Why?
|
Propensity Score | 1 | 2020 | 1781 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2019 | 3130 | 0.030 |
Why?
|
Receptor, Notch1 | 1 | 2016 | 502 | 0.030 |
Why?
|
HLA Antigens | 1 | 2019 | 1382 | 0.030 |
Why?
|
Apoptosis | 2 | 2021 | 9724 | 0.030 |
Why?
|
Acute Disease | 1 | 2023 | 7147 | 0.030 |
Why?
|
Wnt2 Protein | 1 | 2012 | 28 | 0.030 |
Why?
|
Contact Inhibition | 1 | 2012 | 48 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2022 | 2110 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2018 | 1117 | 0.030 |
Why?
|
Intestinal Mucosa | 1 | 2023 | 3037 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 705 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2505 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2924 | 0.030 |
Why?
|
Hepatitis B, Chronic | 1 | 2017 | 393 | 0.030 |
Why?
|
Adipogenesis | 1 | 2015 | 359 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2021 | 1580 | 0.030 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2017 | 428 | 0.030 |
Why?
|
Wilms Tumor | 1 | 2015 | 373 | 0.030 |
Why?
|
Consensus | 1 | 2021 | 2960 | 0.030 |
Why?
|
Metabolomics | 1 | 2020 | 1485 | 0.030 |
Why?
|
Fibrosis | 1 | 2019 | 2029 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2020 | 19233 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3480 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2012 | 399 | 0.030 |
Why?
|
Cell Shape | 1 | 2013 | 375 | 0.030 |
Why?
|
Collagen | 1 | 2020 | 2688 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2021 | 2441 | 0.030 |
Why?
|
Viral Load | 1 | 2020 | 3300 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 12961 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 730 | 0.030 |
Why?
|
Time Factors | 2 | 2016 | 40075 | 0.020 |
Why?
|
Pancreaticoduodenectomy | 1 | 2015 | 503 | 0.020 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4805 | 0.020 |
Why?
|
Autoimmunity | 1 | 2019 | 1350 | 0.020 |
Why?
|
Poly T | 1 | 2010 | 5 | 0.020 |
Why?
|
Cell Size | 1 | 2013 | 643 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2018 | 2715 | 0.020 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2012 | 261 | 0.020 |
Why?
|
Workflow | 1 | 2015 | 847 | 0.020 |
Why?
|
Acetylation | 1 | 2013 | 1084 | 0.020 |
Why?
|
Methylation | 1 | 2013 | 1106 | 0.020 |
Why?
|
Genotype | 2 | 2016 | 12952 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2014 | 561 | 0.020 |
Why?
|
Reverse Transcription | 1 | 2010 | 47 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2015 | 1094 | 0.020 |
Why?
|
Genes, Neoplasm | 1 | 2012 | 376 | 0.020 |
Why?
|
Prospective Studies | 3 | 2020 | 53290 | 0.020 |
Why?
|
Nitriles | 1 | 2015 | 955 | 0.020 |
Why?
|
Genetic Markers | 1 | 2017 | 2634 | 0.020 |
Why?
|
Culture | 1 | 2014 | 633 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2021 | 19905 | 0.020 |
Why?
|
Estrogen Receptor alpha | 1 | 2014 | 577 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 890 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 4751 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2017 | 3144 | 0.020 |
Why?
|
Benzamides | 1 | 2015 | 1379 | 0.020 |
Why?
|
Mesoderm | 1 | 2013 | 686 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 2018 | 9274 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2020 | 2638 | 0.020 |
Why?
|
Tamoxifen | 1 | 2014 | 981 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2017 | 1403 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2076 | 0.020 |
Why?
|
Pregnancy | 2 | 2021 | 29144 | 0.020 |
Why?
|
DNA, Viral | 1 | 2015 | 2227 | 0.020 |
Why?
|
Histone Deacetylases | 1 | 2013 | 728 | 0.020 |
Why?
|
Antioxidants | 1 | 2017 | 1659 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2019 | 2943 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2015 | 1783 | 0.020 |
Why?
|
Organ Transplantation | 1 | 2019 | 1140 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 12073 | 0.020 |
Why?
|
Cell Count | 1 | 2013 | 1856 | 0.020 |
Why?
|
Paclitaxel | 1 | 2016 | 1708 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2015 | 2649 | 0.020 |
Why?
|
Proteins | 1 | 2023 | 6100 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2013 | 789 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2018 | 2418 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3528 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2014 | 1142 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2014 | 1340 | 0.020 |
Why?
|
Heterozygote | 1 | 2014 | 2804 | 0.020 |
Why?
|
Cell Lineage | 1 | 2017 | 2504 | 0.020 |
Why?
|
Young Adult | 3 | 2019 | 56429 | 0.020 |
Why?
|
Prostatectomy | 1 | 2016 | 1890 | 0.020 |
Why?
|
Gene Frequency | 1 | 2014 | 3587 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2010 | 767 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 40559 | 0.020 |
Why?
|
Prostate | 1 | 2015 | 1775 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20130 | 0.020 |
Why?
|
Pyrimidines | 1 | 2019 | 2943 | 0.020 |
Why?
|
United States | 3 | 2021 | 69872 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2019 | 4561 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2134 | 0.020 |
Why?
|
Liver Cirrhosis | 1 | 2017 | 1862 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2014 | 1678 | 0.020 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2007 | 227 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2019 | 4153 | 0.020 |
Why?
|
Breast | 1 | 2014 | 1970 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4372 | 0.020 |
Why?
|
Histocompatibility Testing | 1 | 2007 | 741 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7323 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2017 | 3595 | 0.020 |
Why?
|
Antigens, CD | 1 | 2015 | 4026 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2007 | 648 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2015 | 2962 | 0.010 |
Why?
|
Base Sequence | 1 | 2014 | 12797 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2015 | 4554 | 0.010 |
Why?
|
Boston | 1 | 2015 | 9312 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2007 | 2124 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2015 | 4479 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13409 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3921 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12356 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4042 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8385 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4262 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17446 | 0.010 |
Why?
|
Infant | 1 | 2019 | 35134 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 41005 | 0.010 |
Why?
|
Family | 1 | 2007 | 3147 | 0.010 |
Why?
|
Recurrence | 1 | 2007 | 8340 | 0.010 |
Why?
|
Child | 1 | 2019 | 77709 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 85779 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 35425 | 0.000 |
Why?
|